Cantor Fitzgerald initiated coverage on Verona Pharma with a new price target

4/21/25 8:39:43 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Cantor Fitzgerald initiated coverage of Verona Pharma with a rating of Overweight and set a new price target of $80.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VRNA

Date	Price Target	Rating	Analyst
4/28/2025	$100.00	Buy	TD Cowen
4/21/2025	$80.00	Overweight	Cantor Fitzgerald
1/10/2025	$68.00	Buy	ROTH MKM
10/3/2024	$50.00	Overweight	Wells Fargo
5/22/2023	$35.00 → $38.00	Buy	Jefferies
9/19/2022	$27.00	Outperform	Wedbush
8/26/2022	$31.00	Overweight	Piper Sandler
11/12/2021	$18.00 → $23.00	Buy	Canaccord Genuity